
Paul Hanna, MD, MSc
Director of Onconephrology, Assistant Professor
Locations
- Froedtert Hospital
- Nephrology - Center for Advanced Care - Froedtert Hospital
Specialties
- Nephrology
Languages
- English, Arabic
Education
- MD - Doctor of Medicine
- MSc - Master of Science
Clinical Expertise
- Acute Kidney Injury
- Atypical Hemolytic Uremic Syndrome
- Chronic Kidney Disease-Mineral and Bone Disorder
- Essential Hypertension
- Glomerulonephritis
- Hydronephrosis
- Hyperparathyroidism, Secondary
- Hypertension
- Hypertension, Renal
- Hypertension, Renovascular
- Kidney Diseases
- Kidney Failure, Chronic
Publications
-
Cardiovascular Involvement in ANCA-associated Vasculitis.
(Sarmad A, Ghozloujeh ZG, Hanna PE, Kronbichler A, Geetha D, Heidari-Bateni G, Mathew R, Ahmad M, Mohammed A, Siddiqui S, Abdipour A, Norouzi S.) Nephrol Dial Transplant. 2025 Apr 25 PMID: 40280728 04/26/2025
-
(Vakhshoori M, Hanna PE, Obaidi Z, Chen Wongworawat Y, Abdipour A, Norouzi S.) J Investig Med High Impact Case Rep. 2025;13:23247096251323066 PMID: 40069965 PMCID: PMC11898078 03/12/2025
-
(Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S.) Kidney Int Rep. 2024 Jun;9(6):1897-1902 PMID: 38899179 PMCID: PMC11184235 06/20/2024
-
(Hanna PE, Ouyang T, Tahir I, Katz-Agranov N, Wang Q, Mantz L, Strohbehn I, Moreno D, Harden D, Dinulos JE, Cosar D, Seethapathy H, Gainor JF, Shah SJ, Gupta S, Leaf DE, Fintelmann FJ, Sise ME.) J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):1187-1198 PMID: 38646842 PMCID: PMC11154767 SCOPUS ID: 2-s2.0-85191144047 04/22/2024
-
Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma.
(Mistry K, Zhao S, Strohbehn I, Wang Q, Hanna P, Strohbehn S, Katz-Agranov N, Sullivan RJ, Sise ME.) Nephrol Dial Transplant. 2024 May 31;39(6):1040-1043 PMID: 38389257 SCOPUS ID: 2-s2.0-85194906171 02/23/2024
-
Challenges for optimal care in onconephrology.
(Hanna PE, Chowdhury R, Solhjou Z, Gupta S, Jhaveri KD.) Nephrol Dial Transplant. 2024 Jan 31;39(2):167-169 PMID: 37442629 PMCID: PMC10828197 SCOPUS ID: 2-s2.0-85183980722 07/14/2023
-
(Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S.) Kidney International Reports. June 2024;9(6):1897-1902 SCOPUS ID: 2-s2.0-85189238641 06/01/2024
-
Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer.
(Hanna PE, Strohbehn IA, Moreno D, Harden D, Seethapathy R, Sawtell R, Wang Q, Ouyang T, Katz-Agranov N, Dinulos J, Wander SA, Gupta S, Sise ME.) NPJ Breast Cancer. 2023 Aug 19;9(1):70 PMID: 37598278 PMCID: PMC10439887 08/20/2023
-
(Hanna PE, Wang Q, Strohbehn IA, Moreno D, Harden D, Ouyang T, Katz-Agranov N, Seethapathy H, Reynolds KL, Gupta S, Leaf DE, Sise ME.) JAMA Netw Open. 2023 Jul 03;6(7):e2321715 PMID: 37405775 PMCID: PMC10323710 SCOPUS ID: 2-s2.0-85163940967 07/05/2023
-
(Wang Q, Seethapathy R, Ouyang T, Strohbehn IA, Katz-Agranov N, Hanna P, Madken M, Seethapathy H, Gupta S, Heller HM, Wszolek M, Steele D, Klepeis VE, Rennke H, Sise ME.) Kidney International Reports. December 2023;8(12):2833-2837 SCOPUS ID: 2-s2.0-85173386703 12/01/2023
-
(Hanna PE, Anumolu RK, Motwani SS, Chen KL, Katz-Agranov N, Green-Lingren O, Yilmam OA, Jhaveri KD, Kitchlu A, Kala J, Sise ME, Gupta S.) Kidney International Reports. doi: 10.1016/j.ekir.2024.03.005 03/13/2024
-
Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma
(Mistry K, Zhao S, Strohbehn I, Wang Q, Hanna P, Strohbehn S, Katz-Agranov N, Sullivan RJ, Sise M.) Nephrology Dialysis Transplantation. doi:10.1093/ndt/gfae049 02/22/2024